Lucrezia De Santis - JoVE Visualize

Showing results (1-10 of 4) with videos related to

Pageof 1

Sort By:

Chirurgie (Heidelberg, Germany)|April 28, 2025

[Is the procedure or the patient decisive for prehabilitation?]Lara Braun, Lucrezia De Santis, Alexander Semaan, et al.

Cancer Medicine|May 19, 2025

NSD2 and miRNAs as Key Regulators of Melanoma Response to Romidepsin and Interferon-α2b TreatmentAlessandro De Santis, Lucrezia De Santis, Francesca Rossi, et al.

Molecular Oncology|February 22, 2026

Pre-analytical optimization of cell-free DNA and extracellular vesicle-derived DNA for mutation detection in liquid biopsiesJonas Dohmen, Lucrezia De Santis, Bret M Stephens, et al.

Clinica Chimica Acta; International Journal of Clinical Chemistry|July 5, 2025

Integrating fecal immunochemical testing and methylated SEPT9 for enhanced colorectal cancer Screening: A Multi-Center Case-Control studyJonas Dohmen, Stefanie Rohrbach, Tim Vilz, et al.

Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:

Pageof 1

Chirurgie (Heidelberg, Germany)|April 28, 2025

[Is the procedure or the patient decisive for prehabilitation?]Lara Braun, Lucrezia De Santis, Alexander Semaan, et al.

Cancer Medicine|May 19, 2025

NSD2 and miRNAs as Key Regulators of Melanoma Response to Romidepsin and Interferon-α2b TreatmentAlessandro De Santis, Lucrezia De Santis, Francesca Rossi, et al.

Molecular Oncology|February 22, 2026

Pre-analytical optimization of cell-free DNA and extracellular vesicle-derived DNA for mutation detection in liquid biopsiesJonas Dohmen, Lucrezia De Santis, Bret M Stephens, et al.

Clinica Chimica Acta; International Journal of Clinical Chemistry|July 5, 2025

Integrating fecal immunochemical testing and methylated SEPT9 for enhanced colorectal cancer Screening: A Multi-Center Case-Control studyJonas Dohmen, Stefanie Rohrbach, Tim Vilz, et al.

Pageof 1